Anthony Rullo: chemically modulating proximity Profile
Anthony Rullo: chemically modulating proximity

@LabRullo

Followers
935
Following
5K
Media
47
Statuses
3K

Covalent and multivalent - proximity inducing strategies for basic and translational chemical biology

Joined June 2019
Don't wanna be here? Send us removal request.
@AsAshraf123321
Ashraf Saad, bridging Glycobiology and Oncology!
16 days
Imine-linked covalent organic frameworks: Recent advances in design, synthesis, and application @COF_papers @MOF_papers @Molecular_Cages @POC_Papers https://t.co/9S6208sJw9…
@SmartMat2
SmartMat
16 days
Imine-linked covalent organic frameworks: Recent advances in design, synthesis, and application @COF_papers @MOF_papers @Molecular_Cages @POC_Papers https://t.co/VICqZa5FR0
0
6
15
@HarborSpring
John E. Moses
17 days
🎉 New paper in Drug Discovery Today in collaboration with the Tuveson lab. “Clickable Covalent Metabolite Mimetics (CoMMs)” – nature-inspired scaffolds. Big congrats Elliot, Dharmendra, Shoujun & Adam! 🔗 https://t.co/yr5MQ4N4vh #DrugDiscovery #CovalentDrugs #ClickChemistry
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
1
6
@LabRullo
Anthony Rullo: chemically modulating proximity
18 days
Great chemical review on induced proximity in the context of cellular immunotherapy https://t.co/aaVb51uGNp
0
0
4
@perrinlab
PerrinLab - UBC (posts do not represent UBC)
25 days
With gratitude to reviewers, we are thrilled to report on a new type of hybrid drug: Baited SELEX: Drug-Directed Selection of Aptamers to PSMA for In Vivo Targeting of Prostate Cancer in Mice https://t.co/LusaluC1ND @PCR_news @BeatPCa @prostatecanada @PCFNews @AptamerSociety
Tweet card summary image
pubs.acs.org
We report a selection strategy for linking a drug-pharmacophore to a degenerate DNA library for use in cell- and whole-animal systematic evolution of ligands by exponential enrichment (SELEX) to...
1
2
6
@Glaconde34
Guillaume Laconde
25 days
Development of Dual-Receptor Lysosome-Targeting Chimeras for Protein Degradation | Journal of the American Chemical Society
Tweet card summary image
pubs.acs.org
A growing array of lysosome-targeting chimeras (LYTACs) have recently emerged as therapeutic candidates to treat malignancies and other diseases via targeted protein degradation. We established a...
0
2
14
@ScienceMIT
MIT Science
1 month
"We used a very low dose, almost 100 times lower compared to the traditional small-molecule drug, and the ABC still can achieve much better efficacy compared to the small-molecule drug given on its own," says @chemistrymit postdoc Bin Liu
Tweet card summary image
news.mit.edu
Using nanoparticles shaped like bottlebrushes, MIT chemists can deliver a large range of chemotherapy drugs directly to tumor cells, which could reduce the side effects of treatment.
0
4
5
@ScienceMagazine
Science Magazine
1 month
A new generation of radiotherapies promises a more targeted attack on cancer. Learn more: https://t.co/chj1i58jEe @NewsfromScience
11
147
602
@romeerizwan
Rizwan Romee
1 month
How to make immune cells “invisible” to facilitate allogeneic cell therapies? MIT and Harvard Build “Invisible” Immune Cells That Obliterate Cancer
Tweet card summary image
scitechdaily.com
MIT and Harvard scientists have created engineered CAR-NK cells that can hide from the immune system and more effectively destroy cancer. The cells are designed to suppress immune-rejection signals...
1
4
24
@fabianaperna
Fabiana Perna
1 month
Happy to share my lab’s work out today in @Cancer_Cell demonstrating that multiple myeloma relapses after CAR T therapy frequently express low BCMA levels. We develop novel SEMA4A-directed CAR T cells eradicating MM, especially under BCMA low conditions. https://t.co/cgGMkh7GIy
15
13
73
@peterseeberger
Peter Seeberger
1 month
Controlling the 3D structure of #glycans allows increased binding to proteins- not just a curiosity but a powerful concept to develop better #vaccines
@J_A_C_S
J. Am. Chem. Soc.
1 month
Stapling of β-Glucans Increases Antibody Binding | Journal of the American Chemical Society @peterseeberger @MpiciPotsdam @FU_Berlin
0
2
17
@NatureBiotech
Nature Biotechnology
1 month
Folding-mediated secretion of pure bispecific antibodies https://t.co/yLRuetLJ4w
1
29
159
@NatRevDrugDisc
Nature Reviews Drug Discovery
1 month
Today's Nobel Prize for Physiology or Medicine relates to research on regulatory T cells https://t.co/rUp92Opbx3 For readers interested in harnessing the biology of regulatory T cells to treat disease, here's a comprehensive review https://t.co/4CVfcN5Y2r https://t.co/z83V1d8cOQ
14
533
2K
@MiriamMerad
Miriam Merad, MD, PhD
1 month
Immunology takes center stage again at the #NobelPrize! Congratulations to Mary Brunkow, Fred Ramsdell & Shimon Sakaguchi for uncovering how regulatory T cells maintain immune tolerance—a discovery that transformed our understanding of autoimmunity and cancer immunotherapy
5
65
549
@elonmusknews30
Commentary Elon Musk News
1 month
How many faces do you see?
2K
82
520
@Glaconde34
Guillaume Laconde
2 months
Frustration in the protein-protein interface plays a central role in the cooperativity of PROTAC ternary complexes
Tweet card summary image
nature.com
Nature Communications - PROTACs induce degradation by bridging a target protein and E3 ubiquitin ligase. Here, authors show that protein interface frustration correlates with cooperativity,...
0
4
21
@nchembio
Nature Chemical Biology
2 months
The fusion of intrinsically disordered regions to CARs enhances CAR-T signaling by inducing CAR condensation and enhances CAR sensitivity to low-antigen-expressing cancer cells https://t.co/9kvMmpxfNA
0
2
15